An uncertainty and sensitivity analysis applied to the prioritisation of pharmaceuticals as surface water contaminants from wastewater treatment plant direct emissions.

In this study, the concentration probability distributions of 82 pharmaceutical compounds detected in the effluents of 179 European wastewater treatment plants were computed and inserted into a multimedia fate model. The comparative ecotoxicological impact of the direct emission of these compounds from wastewater treatment plants on freshwater ecosystems, based on a potentially affected fraction (PAF) of species approach, was assessed to rank compounds based on priority. As many pharmaceuticals are acids or bases, the multimedia fate model accounts for regressions to estimate pH-dependent fate parameters. An uncertainty analysis was performed by means of Monte Carlo analysis, which included the uncertainty of fate and ecotoxicity model input variables, as well as the spatial variability of landscape characteristics on the European continental scale. Several pharmaceutical compounds were identified as being of greatest concern, including 7 analgesics/anti-inflammatories, 3 β-blockers, 3 psychiatric drugs, and 1 each of 6 other therapeutic classes. The fate and impact modelling relied extensively on estimated data, given that most of these compounds have little or no experimental fate or ecotoxicity data available, as well as a limited reported occurrence in effluents. The contribution of estimated model input variables to the variance of freshwater ecotoxicity impact, as well as the lack of experimental abiotic degradation data for most compounds, helped in establishing priorities for further testing. Generally, the effluent concentration and the ecotoxicity effect factor were the model input variables with the most significant effect on the uncertainty of output results.

[1]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[2]  C. Delerue-Matos,et al.  Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. , 2010, Journal of hazardous materials.

[3]  Adriano Joss,et al.  Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. , 2009, Water research.

[4]  Thomas Knacker,et al.  Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies , 2010, Integrated environmental assessment and management.

[5]  F. Omil,et al.  Removal of pharmaceutically active compounds in nitrifying-denitrifying plants. , 2005, Water science and technology : a journal of the International Association on Water Pollution Research.

[6]  T. E. Doll,et al.  Fate of pharmaceuticals--photodegradation by simulated solar UV-light. , 2003, Chemosphere.

[7]  M. Rubino,et al.  Degradation of lansoprazole and omeprazole in the aquatic environment. , 2006, Chemosphere.

[8]  Mark A. J. Huijbregts,et al.  Uncertainty in msPAF-Based Ecotoxicological Effect Factors for Freshwater Ecosystems in Life Cycle Impact Assessment , 2007, Integrated environmental assessment and management.

[9]  N Kreuzinger,et al.  Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[10]  Hans Sanderson,et al.  Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. , 2004, Regulatory toxicology and pharmacology : RTP.

[11]  T. Ternes Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[12]  M. Richter,et al.  Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. , 2006, Environmental science & technology.

[13]  Roberta Curini,et al.  Monitoring Natural and Synthetic Estrogens at Activated Sludge Sewage Treatment Plants and in a Receiving River Water , 2000 .

[14]  S. Canonica,et al.  Phototransfomation of ticlosan in surface waters: a relevant elimination process for this widely used biocide--laboratory studies, field measurements, and modeling. , 2002, Environmental science & technology.

[15]  B. Chefetz,et al.  Combined effects of biosolids application and irrigation with reclaimed wastewater on transport of pharmaceutical compounds in arable soils. , 2013, Water research.

[16]  D. Grandjean,et al.  Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. , 2005, Water research.

[17]  K. Thomas,et al.  Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. , 2003, Journal of chromatography. A.

[18]  M. Rubino,et al.  Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms. , 2007, Chemosphere.

[19]  Brett Paull,et al.  Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. , 2009, The Analyst.

[20]  Jeanne Garric,et al.  Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. , 2008, Toxicology letters.

[21]  Michael Zwicky Hauschild GM-troph: A Low Data Demand Ecotoxicity Effect Indicator for Use in LCIA (13+3 pp) , 2007 .

[22]  Mark A J Huijbregts,et al.  Transformation products in the life cycle impact assessment of chemicals. , 2010, Environmental science & technology.

[23]  Xavier Gabarrell,et al.  Accounting for the dissociating properties of organic chemicals in LCIA: an uncertainty analysis applied to micropollutants in the assessment of freshwater ecotoxicity. , 2013, Journal of hazardous materials.

[24]  Antonio Franco,et al.  Estimation of the soil–water partition coefficient normalized to organic carbon for ionizable organic chemicals , 2008, Environmental toxicology and chemistry.

[25]  Peter W. Duenk,et al.  Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field. , 2009, The Science of the total environment.

[26]  D. Barceló,et al.  Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro river basin (NE Spain). , 2012, The Science of the total environment.

[27]  Max Maurer,et al.  Elimination of β-blockers in sewage treatment plants , 2007 .

[28]  M. Thomsen,et al.  Ecotoxicological Quantitative Structure–Activity Relationships for Pharmaceuticals , 2007, Bulletin of environmental contamination and toxicology.

[29]  J. S. Kang,et al.  Increased phototoxicity of hydrochlorothiazide by photodegradation , 2000, Photodermatology, photoimmunology & photomedicine.

[30]  Rolf Altenburger,et al.  Phytotoxicity assessment of diclofenac and its phototransformation products , 2007, Analytical and bioanalytical chemistry.

[31]  Yan-xin Wang,et al.  Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: kinetics and identification of photoproducts. , 2011, Chemosphere.

[32]  P. Verlicchi,et al.  Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review. , 2012, The Science of the total environment.

[33]  J. Payet Assessing toxic impacts on aquatic ecosystems in life cycle assessment (LCA) , 2004 .

[34]  K. Fent,et al.  Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. , 2010, Aquatic toxicology.

[35]  S. Mabury,et al.  Aqueous photochemical reaction kinetics and transformations of fluoxetine. , 2005, Environmental science & technology.

[36]  Michael Zwicky Hauschild Evaluation of Ecotoxicity Effect Indicators for Use in LCIA (10+4 pp) , 2007 .

[37]  Stig Irving Olsen,et al.  Deliverable 4.2: Methodology for including specific biological effects and pathogen aspects into LCA , 2009 .

[38]  Karin Treyer,et al.  Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. , 2011, Water research.

[39]  G. Aherne,et al.  The relevance of the presence of certain synthetic steroids in the aquatic environment , 1989, The Journal of pharmacy and pharmacology.

[40]  A. Fernández-Alba,et al.  Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. , 2010, Water research.

[41]  S. Canonica,et al.  Phototransformation of Triclosan in Surface Waters: A Relevant Elimination Process for This Widely Used BiocideLaboratory Studies, Field Measurements, and Modeling , 2002 .

[42]  Wenjing Fu,et al.  Methods for estimating the bioconcentration factor of ionizable organic chemicals , 2009, Environmental toxicology and chemistry.

[43]  Xuhua Xia,et al.  Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). , 2008, Physiological genomics.

[44]  Mark A. J. Huijbregts,et al.  USEtox—the UNEP-SETAC toxicity model: recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment , 2008 .

[45]  W. Arnold,et al.  Environmental photodegradation of mefenamic acid. , 2005, Chemosphere.

[46]  Richard M. Dinsdale,et al.  The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.

[47]  Roberto Andreozzi,et al.  Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. , 2003, Chemosphere.

[48]  J. Payet,et al.  Assessing Toxic Impacts on Aquatic Ecosystems in LCA , 2005 .

[49]  A. Alder,et al.  Fate of beta-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. , 2010, Water research.

[50]  Anna-Karin Johansson,et al.  Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. , 2006, The Science of the total environment.

[51]  K. Thomas,et al.  The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. , 2006, The Science of the total environment.

[52]  B. Quinn,et al.  The effects of pharmaceuticals on the regeneration of the cnidarian, Hydra attenuata. , 2008, The Science of the total environment.

[53]  Damià Barceló,et al.  Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.

[54]  P. Blánquez,et al.  Multimedia fate modeling and comparative impact on freshwater ecosystems of pharmaceuticals from biosolids-amended soils. , 2013, Chemosphere.

[55]  A. Fernández-Alba,et al.  Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. , 2007, Chemosphere.